Transcription factor-IN-1 (Compound 4e) acts as an inhibitor of transcription factors. It exhibits anticonvulsant activity by antagonizing pentylenetetrazole (PTZ) with an ED50 of 34.5 mg/kg. Additionally, Transcription factor-IN-1 demonstrates antidepressant activity in a rat model.
Target:
GABA Receptor|||Others
* VAT and and shipping costs not included. Errors and price changes excepted
